GoodRx Holdings, Inc. (GDRX)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous close | 7.69 |
| Open | 7.65 |
| Bid | 7.79 x 300 |
| Ask | 7.84 x 800 |
| Day's range | 7.54 - 7.81 |
| 52-week range | 4.14 - 9.37 |
| Volume | |
| Avg. volume | 1,263,579 |
| Market cap | 2.928B |
| Beta (5Y monthly) | 1.40 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Investing.com
Street calls of the week: Upgrades for Micron, Magnite and GoodRx Holdings
Investing.com -- Here is your Pro Recap of the top takeaways from Wall Street analysts for the past week: upgrades for Micron, Magnite and GoodRx Holdings; downgrade for Him Hers Health.
- Insider Monkey
GoodRx Holdings, Inc. (NASDAQ:GDRX) Q1 2024 Earnings Call Transcript
GoodRx Holdings, Inc. (NASDAQ:GDRX) Q1 2024 Earnings Call Transcript May 9, 2024 GoodRx Holdings, Inc. misses on earnings expectations. Reported EPS is $0.08 EPS, expectations were $0.09. GoodRx Holdings, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Ladies and […]
- GuruFocus.com
GoodRx Holdings Inc (GDRX) Q1 2024 Earnings: Navigates Market Challenges with Strategic Adjustments
Performance Aligned with Analyst Projections Amidst Revenue and Adjusted EBITDA Growth
© 2024 Yahoo. All rights reserved.